The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer
Year: 2009
Type: article
Study design: Observational Study
Institutions: Yale University, University of Turin, Ospedale Sant'Anna
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: green
Funder: National Cancer Institute
OpenAlex ID: W1963970141
